ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      0.00%
      US Tech 100
      19,309.20
      0.06%
      Dow Jones
      42,063.36
      0.00%
      Brent Oil
      73.795
      -0.12%
      Bitcoin
      63,428.19
      -0.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Oasmia Pharmaceuticals AB (OASM) Quote

      Oasmia Pharmaceuticals AB

      Oasmia Pharmaceuticals AB (OASM)

      NASDAQ
      1.55
      0.00
      (0.00%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      1.55
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.55
      Bid
      1.01
      Ask
      2.14
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      833.967M
      Previous Close
      1.55
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      538,043,000
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      9.5M
      Net Profit
      -128.74M

      About Oasmia Pharmaceuticals AB

      Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved pro... Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved properties, a reduced side-effect profile, and an expanded therapeutic area. The products and product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients, without the addition of toxic solvents. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.vivesto.com
      Headquarters
      Uppsala, Swe
      Founded
      -

      Ask ADVFN Intelligence (AI)

      OASM Latest News

      More News

      CORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction

      Creating a Scaled Unconventional U.S. Oil Producer with a Premier Williston Basin Acreage Position Totaling 972K Net Acres and Combined 4Q21 Production of 167.8 Thousand Boepd Transaction...

      March 07 2022
      Business Wire

      Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction

      Creating a Scaled Unconventional U.S. Oil Producer with a Premier Williston Basin Acreage Position Totaling 972K Net Acres and Combined 4Q21 Production of 167.8 Thousand Boepd Transaction...

      March 07 2022
      Business Wire

      New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted

      Oasmia Pharmaceutical AB (Nasdaq: OASM) announces that the United States Patent and Trademark Office (USPTO) has issued a notification of allowance of a patent for its unique nanotech method to...

      November 20 2018
      GlobeNewswire Inc.

      Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma

      Overall response rate data from the (RXE) Phase II study conducted in the US and Sweden met its primary end points and treatment with Doxophos Vet was generally well tolerated. Oasmia’s...

      October 03 2018
      GlobeNewswire Inc.

      Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union

      Apealea receives positive CHMP opinion in the European Union for treatment of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer in combination with...

      September 21 2018
      GlobeNewswire Inc.

      Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia

      Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today that it has received marketing approval of Doxophos in...

      August 08 2017
      GlobeNewswire Inc.

      Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets

      Oasmia Pharmaceutical AB (NASDAQ: OASM) has entered into a new exclusive marketing and distributions agreement with Hetero Group (Hetero) with the goal of driving revenue in Russia and other...

      June 14 2017
      GlobeNewswire Inc.

      Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets

      Oasmia Pharmaceutical AB (NASDAQ: OASM) has entered into a new exclusive marketing and distributions agreement with Hetero Group (Hetero) with the goal of driving revenue in Russia and other...

      June 14 2017
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVVENuvve Holding Corporation
      $ 6.70
      (70.92%)
      		5.33M
      TGLTreasure Global Inc
      $ 1.13
      (66.10%)
      		8.41M
      SOXMTradr 2X Long SOXX Monthly ETF
      $ 36.96
      (58.98%)
      		58
      NUKKNukkleus Inc
      $ 0.3124
      (47.01%)
      		23.79M
      BDTXBlack Diamond Therapeutics Inc
      $ 6.6608
      (39.93%)
      		8.51M
      ZJYLJin Medical International Ltd
      $ 3.10
      (-24.02%)
      		47.97k
      AACGATA Creativity Global
      $ 0.40
      (-21.61%)
      		1
      OLMAOlema Pharmaceuticals Inc
      $ 10.80
      (-20.82%)
      		69
      PRFXPainReform Ltd
      $ 0.62
      (-19.60%)
      		76.2k
      ADTXAditxt Inc
      $ 0.314
      (-17.93%)
      		114.32k
      XPONExpion360 Inc
      $ 0.116
      (36.79%)
      		81.49M
      NUKKNukkleus Inc
      $ 0.3124
      (47.01%)
      		23.79M
      LGCBLinkage Global Inc
      $ 0.5397
      (29.02%)
      		14.02M
      BDTXBlack Diamond Therapeutics Inc
      $ 6.6608
      (39.93%)
      		8.51M
      TGLTreasure Global Inc
      $ 1.13
      (66.10%)
      		8.41M

      Discussion

      View Full Feed
      uranium-pinto-beans uranium-pinto-beans 2 minutes ago
      Once considered to be a major force in Silicon Valley, Intel (INTC) in recent times has been marred with technological and financial struggles. It has prompted thousands of layoffs, a suspension of its dividend, and a pause in factory projects amid a costly foundry buildout. Shares of the company ha
      AVGO INTC QCOM
      uranium-pinto-beans uranium-pinto-beans 2 minutes ago
      Once considered to be a major force in Silicon Valley, Intel (INTC) in recent times has been marred with technological and financial struggles. It has prompted thousands of layoffs, a suspension of its dividend, and a pause in factory projects amid a costly foundry buildout. Shares of the company ha
      AVGO INTC QCOM
      TechandBio TechandBio 2 minutes ago
      97% Complete response Tumor kill rate for Breast Cancer safer after 5 years no Pill or IV based medication comes close to IceCure Cryoblation Platform.

      Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical S
      ICCM
      Don Don 2 minutes ago
      Ya realize the yellow brick road and the wizard of oz were fairy tales. Pretty appropriate don’t ya think?
      AABB
      Monksdream Monksdream 2 minutes ago
      NVVE pulling away from the pack
      NVVE
      Beerworld Beerworld 3 minutes ago
      Agreement good
      Middle East not so good!!!
      Catmandoo Catmandoo 3 minutes ago
      Barcharts Update from Hold now 40% Buy..looking good..getting closer to Showtime...
      MWWC
      want2retire want2retire 3 minutes ago
      No it quite clearly is not. It is reporting progress from the September 9th PR, stating the facility is NOW COMPLETE and “proudly announces the initiation of its first production cycle for the BAM-1 parental strains at its newly established production center.”

      And “when fully utilize
      KBLB
      arachnodude arachnodude 3 minutes ago
      Calling today’s PR a 'rehash' of the September 9th one is nothing more than a lazy attempt to downplay actual progress. If you bothered to read beyond the headlines, you’d notice some key differences: the September 9th PR focused on the completion and preparation of the facility, while today’s PR an
      KBLB
      oystersnbeer oystersnbeer 3 minutes ago
      Still tight fisting those $70s ?

      https://res.cloudinary.com/teepublic/image/private/s--4pMUc9EM--/c_crop,x_10,y_10/c_fit,h_1109/c_crop,g_north_west,h_1260,w_1008,x_-67,y_-76/co_rgb:ffffff,e_colorize,u_Misc:One%20Pixel%20Gray/c_scale,g_north_west,h_1260,w_1008/fl_layer_apply,g_north_we
      Surfacetite Surfacetite 3 minutes ago
      Some good power this one.
      XPON
      Number sleven Number sleven 3 minutes ago
      JRoon, I agree. Until recently Amarin had managed to maintain an exclusive arrangement with CVS. I/we don't know how they managed that. This leads me to believe that we can compete with the generic companies. Pharmacy benefit managers are cutthroat. It's possible that we could regain our exclusive c
      CVS
      MightyX MightyX 4 minutes ago
      “Applied Digital Sets Fiscal First Quarter 2025 Earnings Conference Call for Wednesday, October 9, 2024 at 5:00 p.m. Eastern Time
      APLD
      blackhawks blackhawks 4 minutes ago
      Yes
      WeTheMarket WeTheMarket 4 minutes ago
      BYD, have you received any feedback from the information you posted regarding the recent developments with Tritium?
      DCFCQ
      tradernewstip tradernewstip 4 minutes ago
      $CBDW Technical analysis from @barchart
      https://www.barchart.com/stocks/quotes/CBDW/opinion?view=strengthDirection
      CBDW
      Boat Shoes From Yahoo Boat Shoes From Yahoo 4 minutes ago
      Good Morning Warriors! It’s been awhile! Let’s get a WARRIOR headcount.
      Give a thumbs up! Hang in there! The BOAT is just getting warmed up!
      FNMA
      Viewmont Viewmont 4 minutes ago
      $ASII https://x.com/ASII_Inc/status/1836809481864298783
      ASII
      roadkilll roadkilll 4 minutes ago
      STMicro has also taken a steep dive to a 52 week low
      The sector is suffering as they continue down the path of shrinking chips at the expense of profitability. Time to listen to Nvidia CEO Jensen Huang when he says the era of shrinking chips is reached atomic scale, the future lies with mater
      ATOM
      Milesblue42 Milesblue42 5 minutes ago
      ❗️
      Alexulf, your AITX Argument signals INCOMING-DILUTION-IMO❗️

      Well Well said! A good breakdown of AITX potential - as a view of the company
      and stock in the long-term perspective!! A good breakdown of AITX potential - as a view of the company
      AITX
      hweb2 hweb2 5 minutes ago
      Nice $5.1M order on MIND. The commentary sounds bullish too-

      https://finance.yahoo.com/news/mind-technology-announces-source-controller-110000515.html
      JakBqk JakBqk 5 minutes ago
      Evidently several stocks I'm in are/have been waiting for the results of the presidential election before committing to any future plans 🔮. I would too! 😄
      DRNK
      Large Green Large Green 5 minutes ago
      Hey Fred it looks like most attorneys have all withdrawn. What do you make of this now?

      With all these Libor filings with attorneys withdrawing, the end must be only days away.

      412609/20/2024ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL OF RECORD granting (4123) Motion t
      blackhawks blackhawks 6 minutes ago
      Posting one of those four commonwealth states, or a country, would be a no harm no foul situation. Do you consider your Canadian identity a TOS violation?
      train21 train21 6 minutes ago
      $WCVC is it a full bag in one hand and POOP in the other ??
      I have a big bag of NIXON poop ??
      WCVC

      Your Recent History

      NASDAQ
      OASM
      Oasmia Pharmaceuticals AB
      Delayed Upgrade Clock